QNCX – quince therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Quince Therapeutics (NASDAQ:QNCX) had its price target raised by analysts at D. Boral Capital from $4.00 to $5.00. They now have a "buy" rating on the stock.
Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia
Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders [Yahoo! Finance]
Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders
Quince Therapeutics to Participate at Investor Events in December 2025
Form 4 Quince Therapeutics, For: Dec 10 Filed by: Thye Dirk
Form 4 Quince Therapeutics, For: Dec 05 Filed by: Hannah Brendan
Form SCHEDULE 13G/A Quince Therapeutics, Filed by: Nantahala Capital Management, LLC
Form 8-K Quince Therapeutics, For: Nov 12
Form 10-Q Quince Therapeutics, For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.